lusutrombopag · Vancocin Italia · NDA 210923
Mulpleta
Earliest generic entry, as listed
29 Sep 2031
Blocked by patent: US 9427402.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9427402 | product | 29 Sep 2031 |
| US 8530668 | substance, product | 21 Jan 2030 |
| US 8889722 | substance, product | 29 Jul 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 210923 · 001 · RLD | tablet, oral | 3MG | 29 Sep 2031 |